(GMRE) Global Medical REIT - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37954A2042

Healthcare Facilities, Medical Properties, Real Estate, Leasing, Management

GMRE EPS (Earnings per Share)

EPS (Earnings per Share) of GMRE over the last years for every Quarter: "2020-03": 0.06, "2020-06": 0.04, "2020-09": -0.19, "2020-12": 0.05, "2021-03": 0.06, "2021-06": 0.07, "2021-09": 0.08, "2021-12": 0.08, "2022-03": 0.06, "2022-06": 0.03, "2022-09": 0.12, "2022-12": -0.09, "2023-03": 0.03, "2023-06": 0.2, "2023-09": 0.07, "2023-12": 0.01, "2024-03": 0.03, "2024-06": -0.03, "2024-09": 0.05, "2024-12": 0.04, "2025-03": 0.05,

GMRE Revenue

Revenue of GMRE over the last years for every Quarter: 2020-03: 21.533, 2020-06: 22.036, 2020-09: 25.055, 2020-12: 24.895, 2021-03: 27.325, 2021-06: 28.2, 2021-09: 29.967, 2021-12: 30.312, 2022-03: 31.875, 2022-06: 33.679, 2022-09: 35.406, 2022-12: 36.306, 2023-03: 36.23, 2023-06: 36.317, 2023-09: 35.487, 2023-12: 32.931, 2024-03: 35.069, 2024-06: 34.214, 2024-09: 34.175, 2024-12: 34.952, 2025-03: 34.618,

Description: GMRE Global Medical REIT

Global Medical REIT Inc. (GMRE) is a net-lease medical real estate investment trust that specializes in acquiring healthcare facilities and leasing them to reputable healthcare providers, including physician groups and regional and national healthcare systems, generating stable rental income.

As a Health Care REIT, GMREs business model is centered around providing essential healthcare infrastructure to medical professionals, allowing them to focus on delivering quality patient care. With a diverse portfolio of properties, GMRE is positioned to benefit from the growing demand for healthcare services in the United States.

From a technical analysis perspective, GMREs stock price has been trending downwards, with the current price of $6.19 being significantly lower than its 52-week high of $9.22. The stock is currently trading slightly above its 20-day Simple Moving Average (SMA) of $6.16, indicating a potential stabilization. However, the 50-day SMA and 200-day SMA are still trending downwards, suggesting a longer-term bearish trend.

Using a combination of technical and fundamental analysis, we can forecast that GMREs stock price may experience a short-term bounce if it can sustain its current level above the 20-day SMA. However, the high P/E ratio of 209.67 and relatively low Return on Equity (RoE) of 1.48% may indicate underlying fundamental challenges. Assuming the company can maintain its current dividend yield and continue to grow its rental income, a potential price target could be around $7.50, representing a 21% increase from current levels. However, this would require a significant improvement in the companys earnings and a reversal of the current bearish trend.

Investors should closely monitor GMREs future earnings reports and watch for any changes in the companys guidance or outlook. Additionally, a sustained move above the 50-day SMA of $6.73 could be a bullish indicator, potentially paving the way for further gains.

Additional Sources for GMRE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GMRE Stock Overview

Market Cap in USD 942m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 2016-06-29

GMRE Stock Ratings

Growth Rating -35.7
Fundamental 12.1
Dividend Rating 73.3
Rel. Strength -22.5
Analysts 3.9 of 5
Fair Price Momentum 7.24 USD
Fair Price DCF 5.06 USD

GMRE Dividends

Dividend Yield 12m 10.15%
Yield on Cost 5y 10.22%
Annual Growth 5y 0.98%
Payout Consistency 95.6%
Payout Ratio %

GMRE Growth Ratios

Growth Correlation 3m -39.7%
Growth Correlation 12m -79.3%
Growth Correlation 5y -61.7%
CAGR 5y -0.43%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m -1.00
Alpha -25.24
Beta 0.534
Volatility 25.53%
Current Volume 470.7k
Average Volume 20d 759.7k
Stop Loss 6.9 (-3.2%)
What is the price of GMRE shares?
As of July 12, 2025, the stock is trading at USD 7.13 with a total of 470,657 shares traded.
Over the past week, the price has changed by +0.14%, over one month by +14.53%, over three months by +4.54% and over the past year by -16.09%.
Is Global Medical REIT a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Global Medical REIT is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.14 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GMRE is around 7.24 USD . This means that GMRE is currently overvalued and has a potential downside of 1.54%.
Is GMRE a buy, sell or hold?
Global Medical REIT has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy GMRE.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for GMRE share price target?
According to our own proprietary Forecast Model, GMRE Global Medical REIT will be worth about 7.9 in July 2026. The stock is currently trading at 7.13. This means that the stock has a potential upside of +10.8%.
Issuer Target Up/Down from current
Wallstreet Target Price 9.1 27.5%
Analysts Target Price 10.2 42.5%
ValueRay Target Price 7.9 10.8%